Compare Royal Caribbean Cruises Ltd (RCL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Caribbean Cruises Ltd vs Relay Therapeutics Inc. Common Stock — how do they compare? Royal Caribbean Cruises Ltd trades at $283.29 (market cap $75.51B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 19.2× Relay Therapeutics Inc. Common Stock's market cap, and Royal Caribbean Cruises Ltd pays a 2.13% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royal Caribbean Cruises Ltd for 85 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RCL | RLAY | |
|---|---|---|
Market Cap | $75.51B | $3.94B |
Volume | 2,408,997 | 3,432,928 |
Sector | Consumer Cyclical | Health |
52-Week High | $348.03 | $20.75 |
52-Week Low | $230.30 | $6.03 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $98.15B | $3.06B |
Dividend Yield | 2.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $281.39, down 2.58% on the day, amid mixed technical signals with bullish moving averages but overbought RSI levels. Fundamentally, the company shows strong recovery with revenue growing from $8.8B in 2022 to $17.9B in 2025 and net income reaching $4.3B. Recent developments include a $3 billion investment in Sandals Resorts and positive analyst sentiment with 51% buy ratings.
The outlook remains positive with analyst consensus target of $346.67 suggesting 23% upside potential. Key opportunities include expanding resort operations and strong booking trends, while risks involve high debt levels, fuel cost volatility, and execution challenges from the Sandals acquisition. The stock presents a growth opportunity with manageable risks for long-term investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
